Delayed recurrences and survival after relapse in patients initially treated with intraperitoneal chemotherapy for advanced ovarian cancer: A Gynecologic Oncology Group study

Journal article

Peer reviewed

Daniel Stuart Kapp, James Java, Thomas J. Herzog, Maurie Markman, Deborah Kay Armstrong, Bradley J. Monk and John K. Chan

Journal of clinical oncology, Vol.33(15_suppl), pp.5577-5577

05/20/2015

Abstract

Abstract only

4 Record Views

Title: Delayed recurrences and survival after relapse in patients initially treated with intraperitoneal chemotherapy for advanced ovarian cancer: A Gynecologic Oncology Group study
Creators: Daniel Stuart Kapp - Stanford University
James Java - Gynecologic Oncology Group
Thomas J. Herzog - University of Cincinnati
Maurie Markman - Cancer Treatment Centers of America
Deborah Kay Armstrong - Sidney Kimmel Cancer Center
Bradley J. Monk - University of Arizona
John K. Chan - Palo Alto Medical Foundation
Publication Details: Journal of clinical oncology, Vol.33(15_suppl), pp.5577-5577
Identifiers: 991005968883602656
Academic Unit: Obstetrics & Gynecology
Language: English
Resource Type: Journal article